Macarimbor, Payadoc S.
HRN: 24-96-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2024
CIPROFLOXACIN 500MG (TAB)
05/07/2024
05/13/2024
PO
500mg
BID
Cystitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes